{"id":"tp-62125","type":"article-newspaper","title":"Novartis Says AI Could Cut Drug Development From 12 Years to Eight","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/62125","datePublished":"2026-11-20T14:43:23.000Z","dateModified":"2026-11-20T14:43:23.000Z","language":"en","abstract":"CEO Vasant Narasimhan said AI is speeding candidate discovery and clinical operations. Novartis is targeting a higher success rate for drugs entering human testing.","section":"Business","references":[]}